← Leaderboards
Erguang Li
Scripps Research Institute
$1,806,432
Attributed
$1,806,432
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.1K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,806,432 · 2
By mechanism
R01$1,536,752 · 1
K22$269,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Glen R. Nemerow$12,786,328
- Vijay S Reddy$6,048,606
- Wendy L Havran$20,304,962
- Linda M Columbus$5,589,545
- Marianne Manchester$18,521,680
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionEnzyme Linked Immunosorbent AssayTransfection /Expression VectorPolymerase Chain ReactionFlow CytometryReceptor Mediated EndocytosisLaboratory MouseAntibodyTissue /Cell CultureNeoplasm /Cancer TherapyColorectal NeoplasmsBacteria Infection MechanismMatrix Assisted Laser Desorption IonizationBacterial Cytopathogenic EffectGuanine Nucleotide Binding ProteinMass SpectrometryMembrane ProteinsBiotechnologyBiological Signal TransductionGenetically Modified AnimalsChlamydiaceaeGene Delivery SystemAdenoviridaeCytoskeletal Proteins
Grant awards (7)
Antibody-modified adenoviral vectors for tumor targeting$295,881
R01 · FY2007 · CA · contact PI
Antibody-modified adenoviral vectors for tumor targeting$304,718
R01 · FY2006 · CA · contact PI
Antibody-modified adenoviral vectors for tumor targeting$312,051
R01 · FY2005 · CA
Antibody-modified adenoviral vectors for tumor targeting$312,051
R01 · FY2004 · CA
Antibody-modified adenoviral vectors for tumor targeting$312,051
R01 · FY2003 · CA
Biology of Chlamydia Pneumoniae Cell Entry$108,000
K22 · FY2003 · AI
Biology of Chlamydia Pneumoniae Cell Entry$161,680
K22 · FY2002 · AI